Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

The effect of evinacumab on the clinical outcomes of dyslipidemia: A systematic review of randomized controlled trials.

BACKGROUND Residual atherosclerotic cardiovascular disease risk remains substantial despite optimal conventional lipid-lowering therapy, particularly in patients with persistently elevated low-density lipoprotein cholesterol (LDL-C). Evinacumab, a monoclonal antibody targeting angiopoietin-like protein 3, represents a...

R. Shahid, Syed Mohammad Habib, M. Awan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.